10 Results for "

α5β2γ2

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "α5β2γ2" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-120051
CAS No.: 1398496-82-6
Purity:  98.40%
Synonyms: S44819; Egis-13529
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Afizagabar (S44819) is a first-in-class, competitive, and selective antagonist at the GABA-binding site of the α5-GABAAR, with an IC50 of 585 nM for α5β2γ2 and a Ki of 66 nM for α5β3γ2. Afizagabar enhances hippocampal synaptic plasticity and exhibits pro-cognitive efficacy .
loading...
    loading...
Cat. No.: HY-W013150
CAS No.: 82626-01-5
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Alpidem, an anxiolytic agent, is an orally active and brain-penetrant GABAA receptor ligand, binds to α1β2γ2 subunit-containing GABAA receptors (IC50 of 17 nM) over α5β2γ2 subunit-containing GABAA receptors (IC50 of >10 μM). Alpidem modulates calcium-induced mitochondrial permeability transition, induces glutathione depletion and hepatocyte necrosis, potentiates TNF-α toxicity, inhibits marble-burying and locomotor activity, enhances stressed rodent feeding behavior, and exerts anticonvulsant effects. Alpidem can be used for the research of anxiety, anxiety disorders, and convulsions .
loading...
    loading...
Cat. No.: HY-120874
CAS No.: 1614245-70-3
Purity:  99.29%
Synonyms: PF-06372865; CVL-865
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Darigabat (PF-06372865) is an orally active, α2/α3/α5 subtype-selective GABAA positive allosteric modulator (PAM). Darigabat is a high affinity ligand at GABAA receptors containing α1/α2/α3/α5 subunits (Kis of 2.9 nM, 21 nM, 134 nM for α2, α1 PAM, α2 PAM, respectively), with low affinity for α4/α6 subunits. Darigabat can across the blood-brain barrier (BBB). Darigabat has anxiolytic activity and has the potential for epilepsy .
loading...
    loading...
Cat. No.: HY-103512
CAS No.: 628690-75-5
Purity:  98.99%
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

TP003 is a non-selective benzodiazepine site agonist with EC50s of 20.3, 10.6, 3.24, 5.64 nM for α1β2γ2, α2β3γ2, α3β3γ2, α5β2γ2, respectively. TP003 induces anxiolysis via α2GABAA receptors .
loading...
    loading...
Cat. No.: HY-139226
CAS No.: 716-11-0
Synonyms: 2-Guanidine-4-methylquinazoline
Target:  

GABA Receptor

Research Areas:  

Inflammation/Immunology

GMQ is an acid-sensing ion channel modulator, competitive GABAAR antagonist. GMQ preferentially, potently, competitively inhibits GABAARs. GMQ inhibits α1β2, α1β2γ2, α4β2γ2 and α5β2γ2 GABAARs. GMQ enhances neuronal excitation through inhibition of GABAergic transmission. GMQ has anti-histamine effects in the enteric system, inhibiting gastric acid secretion .
loading...
    loading...
Cat. No.: HY-19438
CAS No.: 90808-12-1
Synonyms: RU 32698
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Divaplon is a GABA receptor agonist with the EC50 values of 31 and 2 nM for α3β2γ2 and α5β2γ2, respectively. Divaplon shows anxiolytic activity .
loading...
    loading...
Cat. No.: HY-W013150R
CAS No.: 82626-01-5
Research Areas:  

Neurological Disease

Alpidem (Standard) is the analytical standard of Alpidem (HY-W013150). This product is intended for research and analytical applications. Alpidem, an anxiolytic agent, is an orally active and brain-penetrant GABAA receptor ligand, binds to α1β2γ2 subunit-containing GABAA receptors (IC50 of 17 nM) over α5β2γ2 subunit-containing GABAA receptors (IC50 of >10 μM). Alpidem modulates calcium-induced mitochondrial permeability transition, induces glutathione depletion and hepatocyte necrosis, potentiates TNF-α toxicity, inhibits marble-burying and locomotor activity, enhances stressed rodent feeding behavior, and exerts anticonvulsant effects. Alpidem can be used for the research of anxiety, anxiety disorders, and convulsions.
loading...
    loading...
Cat. No.: HY-W013150S
CAS No.: 1189962-23-9
Alpidem-d14 is the deuterium labeled Alpidem (HY-W013150) . Alpidem, an anxiolytic agent, is an orally active and brain-penetrant GABAA receptor ligand, binds to α1β2γ2 subunit-containing GABAA receptors (IC50 of 17 nM) over α5β2γ2 subunit-containing GABAA receptors (IC50 of >10 μM). Alpidem modulates calcium-induced mitochondrial permeability transition, induces glutathione depletion and hepatocyte necrosis, potentiates TNF-α toxicity, inhibits marble-burying and locomotor activity, enhances stressed rodent feeding behavior, and exerts anticonvulsant effects. Alpidem can be used for the research of anxiety, anxiety disorders, and convulsions.
loading...
    loading...
Cat. No.: HY-185007
CAS No.: 1849624-82-3
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

LI-633 is a selective and orally active GABAA receptor positive allosteric modulator (PAM) with a Ki of 21 nM. LI-633 produces robust potentiation of GABA-induced inward current, with EC50 values ranging from 8 nM (α5β2γ2) to 128 nM (α3β2γ2). LI-633 potentiates muscimol-induced GABAergic currents in rat dorsal root ganglion (DRG) neurons with an EC50 of 70.4 nM. LI-633 can be used for the study of visceral pain .
loading...
    loading...
Cat. No.: HY-145258
CAS No.: 1808463-81-1
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

GABAA receptor agent 6 (compound 2027) is a potent γ-GABAAR antagonist with an Ki of 0.56 µM. GABAA receptor agent 6 shows γ-GABAAR antagonist activity with low cellular membrane permeability .
loading...
    loading...